The influence of ligand organization on the rate of uptake of gold nanoparticles by colorectal cancer cells

Biomaterials

Volumn 32, Issue 36, 2011, Pages 9776-9784

  Lund, Torben ^a   Callaghan, Martina F ^a   Williams, Phil ^c   Turmaine, Mark ^b   Bachmann, Christof ^c   Rademacher, Tom ^b,c   Roitt, Ivan M ^a   Bayford, Richard ^a  

^a MIDDLESEX UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cell culture; Colon cancer cells; Gold nanoparticles; Thiol bonds

Indexed keywords

BI-LAYER; CELL DENSITY; COLON CANCER CELLS; COLORECTAL CANCER CELL; GOLD NANOPARTICLES; GOLD PARTICLES; GROWTH MEDIUM; IN-VITRO; LIGAND ORGANIZATION; STRUCTURAL ORGANIZATION; THIOL BONDS;

CELL CULTURE; CELL MEMBRANES; CHEMICAL PROPERTIES; DISEASES; GLUCOSE; GOLD; GOLD COATINGS; LIGANDS;

NANOPARTICLES;

DUAL LIGAND GOLD NANOPARTICLE; GLUCOSE; GLUTATHIONE; GOLD NANOPARTICLE; SINGLE LIGAND GOLD NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL DENSITY; CELL MEMBRANE; COLORECTAL CANCER; CULTURE MEDIUM; DIFFUSION; ELECTRON MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ENDOCYTOSIS; GLUCOSE; GLUTATHIONE; GOLD; HUMANS; LIGANDS; METAL NANOPARTICLES;

EID: 80054067252     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.09.018     Document Type: Article

References (36)

1. Davis M.E., Zuckerman J.E., Choi C.H., Seligson D., Tolcher A., Alabi C.A., et al. Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature 2010, 464:1067-1070.
2. El-Sayed I.H. Nanotechnology in head and neck cancer: the race is on. Curr Oncol Rep 2010, 12:121-128.
3. El-Sayed I.H., Huang X., El-Sayed M.A. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett 2006, 239:129-135.
4. Han G., You C.C., Kim B.J., Turingan R.S., Forbes N.S., Martin C.T., et al. Light-regulated release of DNA and its delivery to nuclei by means of photolabile gold nanoparticles. Angew Chem Int Ed 2006, 45:3165-3169.
5. Patra C.R., Bhattacharya R., Wang E., Katarya A., Lau J.S., Dutta S., et al. Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent. Cancer Res 2008, 68(6):1970-1978.
6. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K., Han M.S., Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312:1027-1030.
7. West J.L., Halas N.J. Engineered nanomaterials for biophotonics applications: improving sensing, imaging, and therapeutics. Ann Rev Biomed Eng 2003, 5:285-292.
8. Lewin M., Carlesso N., Tung C.H., Tang X.W., Cory D., Scadden D.T., et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotech 2000, 18:410-414.
9. Somers R.C., Bawendi M.G., Nocera D.G. CdSe nanocrystal based chem-/bio- sensors. Chem Soc Rev 2007, 36:579-591.
10. Weissleder R. Molecular imaging in cancer. Science 2006, 312:1168-1171.
11. Weinberg R.A. The biology of cancer 2006, Garland Science, London.
12. Wong C., Stylianopoulos T., Cui J., Martin J., Chauhan V.P., Jiang W., et al. Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Nat Acad Sci USA 2011, 108:2426-2431.
13. Baish J.W., Stylianopoulos T., Lanning R.M., Kamoun W.S., Fukumura D., Munn L.L., et al. Scaling rules for diffusive drug delivery in tumor and normal tissues. Proc Nat Acad Sci USA 2011, 108:1799-1803.
14. Roduner E. Size matters: why nanomaterials are different. Chem Soc Rev 2006, 35:583-592.
15. Verma A., Uzun O., Hu Y., Hu Y., Han H.S., Watson N., et al. Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. Nat Mater 2008, 7:588-595.
16. Leduc C., Jung J.M., Carney R.R., Stellacci F., Lounis B. Direct investigation of intracellular presence of gold nanoparticles via photothermal heterodyne imaging. ACS Nano 2011, 5:2587-2592.
17. Hung A., Mwenifumbo S., Mager M., Kuna J.J., Stellacci F., Yarovsky I., et al. Ordering surfaces on the nanoscale: implications for protein adsorption. J Am Chem Soc 2011, 133:1438-1450.
18. Li X., Zhou H., Yang L., Du G., Pai-Panandiker A.S., Huang X., et al. Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles. Biomaterials 2011, 32:2540-2545.
19. Dang C.V. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res 2010, 70:859-862.
20. DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008, 7:11-20.
21. Vander Heiden M.G., Locasale J.W., Swanson K.D., Sharfi H., Heffron G.J., Amador-Noguez D., et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 2010, 329:1492-1499.
22. Christofk H.R., Vander Heiden M.G., Harris M.H., Ramanathan A., Gerszten R.E., Wei R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
23. Christofk H.R., Vander Heiden M.G., Wu N., Asara J.M., Cantley L.C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 2008, 452:181-186.
24. Karwatsky J., Daoud R., Cai J., Gros P., Georges E. Binding of a photoaffinity analogue of glutathione to MRP1 (ABCC1) within two cytoplasmic regions (L0 and L1) as well as transmembrane domains 10-11 and 16-17. Biochemistry 2003, 42:3286-3294.
25. Hong R., Han G., Fernandez J.M., Kim B.J., Forbes N.S., Rotello V.M. Glutathione-mediated delivery and release using monolayer protected nanoparticle carriers. J Am Chem Soc 2006, 128:1078-1079.
26. Lagzi I., Kowalczyk B., Wang D., Grzybowski B.A. Nanoparticle oscillations and fronts. Angew Chem Int Ed 2010, 49:8616-8619.
27. Zhang L.W., Monteiro-Riviere N.A. Mechanisms of quantum dot nanoparticle cellular uptake. Toxicol Sci 2009, 110:138-155.
28. Alexis F., Pridgen E., Molnar L.K., Farokhzad O.C. Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 2008, 5:505-515.
29. Clift M.J., Rothen-Rutishauser B., Brown D.M., Duffin R., Donaldson K., Proudfoot L., et al. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol App Pharm 2008, 232:418-427.
30. Xiao Y., Forry S.P., Gao X., Holbrook R.D., Telford W.G., Tona A. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake. J Nanobiotech 2010, 8:13.
31. Duan H., Nie S. Cell-penetrating quantum dots based on multivalent and endosome-disrupting surface coatings. J Am Chem Soc 2007, 129:3333-3338.
32. Jaiswal J.K., Mattoussi H., Mauro J.M., Simon S.M. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotech 2003, 21:47-51.
33. Ryman-Rasmussen J.P., Riviere J.E., Monteiro-Riviere N.A. Surface coatings determine cytotoxicity and irritation potential of quantum dot nanoparticles in epidermal keratinocytes. J Invest Derm 2007, 127:143-153.
34. Arvizo R.R., Miranda O.R., Thompson M.A., Pabelick C.M., Bhattacharya R., Robertson J.D., et al. Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett 2010, 10:2543-2548.
35. Leroueil P.R., Hong S., Mecke A., Baker J.R., Orr B.G., Banaszak Holl M.M. Nanoparticle interaction with biological membranes: does nanotechnology present a Janus face?. Acc Chem Res 2007, 40:335-342.
36. Thoren P.E., Persson D., Isakson P., Goksor M., Onfelt A., Norden B. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. Biochem Biophys Res Com 2003, 307:100-107.